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Development and Application of Quinone Cofactor Mimic Catalysis  
 
Benjamin John Haugeberg 
 
 Organocatalysis is a synthetic field of ever increasing development and utility. Of the 
reactions and small molecule catalysts developed over the last 20 years, a considerable portion 
have been inspired by cofactors that are important to biological systems. Research in the Clift 
group focuses on developing modes for catalysis through applications of quinone cofactor 
mimics.  
 Our studies were motivated by developing a new synthesis of β-amino acids through 
quinone-catalyzed oxidative-decarboxylation. In this process, we developed a protocol for 
quinone-catalyzed oxidative-decarboxylation of α-aryl amino acids in which homologation 
products were isolated following Mukaiyama−Mannich addition. In all, isolated 20 homologated 
products (15-95% yields) in first demonstration of quinone-catalyzed oxidative-decarboxylation 
of α-aryl amino acids. 
 Following the development of quinone-catalyzed oxidative-decarboxylation, we sought 
to explore the potential of quinone catalysts in related oxidative C–C bond cleavage reactions. 
Initial studies on the development of a protocol for the deformylation of amino alcohols is shown 
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1.1: The Development of Organocatalysis  
Organocatalysis is the use of small molecules to catalyze organic transformations. The 
merger of organocatalysis into a single field is relatively new. Over that last century, sporadic 
examples of reactions utilizing small organic molecules as catalysts have been developed, but have 
been considered isolated occurrences. Beginning in the late 1990s, the number of publications 
describing emerging organocataytic processes began increasing significantly. In a review, 
MacMillan noted that between 1998 and 2008, over 1500 publications describing organocatalysis 
in more than 130 discrete reaction types had been described.1 Today, organocatalysis is now 
considered a standard means for reaction development. 
Figure 1.1: Number of Publications of Organocataytic Reactions  
 
In the same review, MacMillan credits the rapid growth of organocatalysis to, “first, the 
conceptualization of the field; second, the advantages of organocataytic research; and, third the 





organocatalysis as a serious branch of synthetic chemistry drove initial reaction development, the 
advantages of organocatalysis motivated researchers to develop generic modes of activation, 
induction, and reactivity. Organocatalysis has many advantages: the relative cost to make and use 
them is low when compared to other modes of catalysis, a large pool of chiral molecules exists to 
enable synthesis of new catalysts, and the catalysts are generally non-toxic and insensitive to 
exposure to moisture and air and they are relatively simple to use. These qualities have made 
organocatalysis an expanding field that continues to grow.2  
The origin of organocatalysis is often traced back to the Hajos–Parrish reaction. (Scheme 
1.1). This is one of the first accounts of a small molecule catalyzed an asymmetric transformation.3 
The chemistry was developed for the synthesis of new intermediates and natural products, such as 
steroids, in asymmetric fashion. In their report, Hajos and Parrish use 3 mol % of a L-proline 
catalyst (I-2) to promote an intramolecular enantioselective aldol cyclization of triketone I-1 to 
form optically enriched bicyclic diketone I-4 in 71% yield. This is the first example of an 
asymmetric reaction carried out using a chiral organic molecule. 







The Hajos–Parrish reaction later inspired many new enamine catalysts and subsequent 
reactions many years after the initial discovery. Some examples of these developments includes 
List’s proline catalyzed aldols,4 Jørgensen’s prolinol catalyst,5 MacMillan’s iminium Diels–
Alder,6 and many more.7 While the conceptualization of the Hajos–Parrish reaction was 
undoubtedly influenced by previous reactions, 74 an equally important and influential discovery 
was made in the 1960s describing a biological variant of asymmetric enamine catalysis. In nature, 
aldolase enzymes catalyze intermolecular aldol reactions (Scheme 1.2). This enzymatic reaction 
differs fundamentally from proline-based enamine catalysis in that a primary amine in a lysine 
residue is used.8 This process did not directly influence the work of Hajos and Parrish, but there is 
a clear parallel between the Hajos–Parrish reaction and enzymatic aldol reactions.  
Scheme 1.2: Lysine Catalyzed Aldol by Fructose Bisphosphate Aldolase 
 
 
In studying enzymes and other biological processes over the past century, a number of 





chemical transformations in enzymatic systems. These molecules are commonly referred to as 
cofactors. Under the circumstances described by MacMillan, researchers realized that cofactors 
found in nature could be used as a platform to develop many important synthetic transformations. 
Since then, the field or organocatalysis has seen a surge in the development of many biologically-
inspired organocatalysts and many new reactions have emerged as a result. Some of the most 
influential cofactors include: thiamine, pyridoxal 5'-phosphate (PLP), and nicotinamide adenine 
dinucleotide (NADH). 
1.2: Thiamine: Nature’s N-Heterocyclic Carbene Catalyst 
Thiamine, commonly known as vitamin B1, is a natural thiazolium salt involved as an N-
heterocyclic carbene (NHC) in many enzymatic processes.9 This coenzyme was first isolated by 
Dutch chemists Petrus and Donath in the 1920s and the structure was determined by Williams in 
1936 (I-11) without knowledge of its function.10,11 Later it was discovered this thiazolium salt 
exists more commonly as thiamine pyrophosphate (TPP, I-12) in biological environments (Figure 
1.2).12  
Figure 1.2: Thiamine and Thiamine Diphosphate (TPP) 
 
 
In the 1950s, Mizuhara and co-workers determined the catalytic role of thiamine in 





concentrations of thiamine hydrochloride (I-11) in alkaline solution catalyzed a benzoin 
condensation and subsequent formation of acetoin (I-14) from acetaldehyde (I-13).13 From their 
seminal discoveries, thiamine and TPP have been shown to carry out a number of carbene 
catalyzed reactions in biological systems.9,12  
Scheme 1.3: Thiamine-Catalyzed Benzoin Condensation  
 
 
By the time the function of thiamine had been discovered in the 1950s, carbene chemistry 
had been relatively well established.14,15 The discovery of the biological role of thiamine prompted 
the development of NHC chemistry. The development of the field was accelerated when Breslow 
proposed a mechanism for the NHC-catalyzed benzoin condensation.16 In the proposed 
mechanism, he describes generation of a carbene through a deprotination of I-15, to give thiazol 
I-16,  which can be drawn as carbene I-18 (Scheme 1.4). NHC I-18 then adds to aldehyde I-17 to 
form I-19, which goes on to form the so-called Breslow intermediate (I-20). This species acts as 
a nucleophile and will add to another molecule of benzaldehyde to give intermediate I-21. The 
NHC is then eliminated to give the benzoin product I-22, thereby completing the catalytic cycle. 






Scheme 1.4: Proposed Mechanism for the NHC-Catalyzed Benzoin Condensation 
 
 
Since the discovery of thiamine and the studies carried out by Breslow, NHC catalysis has 
been used to develop many stable carbene reagents and many organocataytic reactions. One 
particular process that was developed based on thiamine derivatives is the Stetter reaction.18 
Enders and co-workers developed a chiral thiazolium salt I-24 in investigations for the 
development of asymmetric variants of the Stetter reaction (Scheme 1.5).19 The intramolecular 
reaction shows the conversion of I-23 to bicyclic I-25 in modest yields and ee, but provides an 





Scheme 1.5: NHC Catalyzed Asymmetric Stetter Reaction  
 
From these early examples, many selective and high yielding NHC-catalyzed processes 
have been developed.  
1.3 Pyridoxal 5'-Phosphate (Vitamin B6): A Versatile Cofactor 
Another important cofactor found in nature is pyridoxal 5'-phosphate (PLP, Figure 1.3). It 
was first discovered by Grygory in 1934 and termed vitamin B6.20 Since the discovery, pyridoxal 
5'-phosphate (I-26) has been studied extensively owing to its versatile catalytic utility. In nature, 
PLP cofactors are responsible for promoting transamination, deamination, decarboxylation, 
elimination, and racemization reactions of amino acids.21 Given its biological prevalence and 
fundamental importance, mechanisms of PLP-catalyzed reactions are now routinely covered in 
biology textbooks.9, 22-24 






Aminotransferases utilize PLP in transamination processes. Scheme 1.6 shows the first 
half-reaction where a lysine residue initiates proton abstraction from the glutamate condensed to 
PLP (I-26), yielding the quinonoid intermediate I-28. Reprotonation of the cofactor by that lysine 
lends intermediate I-29, which is subsequently hydrolyzed to release α-ketoglutarate (not 
shown).19 In a comprehensive catalytic cycle, a subsequent reaction with a different α-ketoacid 
would generate the corresponding amino acid and return the PLP cofactor. 
Scheme 1.6: PLP-Promoted Transamination of Aminotransferases    
 
 
PLP is also responsible for amino acid racemization in biological systems. Bacterial 
alanine racemase promotes the stereoconversion of L-alanine using a PLP cofactor. (Scheme 
1.7).19 In this process, alanine condenses to a PLP cofactor to lend imine I-30, which then 
undergoes a tyrosine promoted deprotonation to give intermediate I-31. A nearby enzyme bound 








Scheme 1.7: PLP-Catalyzed Racemization 
 
 
Given PLP’s importance and versatility in biological systems, interest in PLP mimics and 
their reaction capabilities has been pursued. In an early example, Maley and Bruice showed that a 
PLP mimic 1-methyl-4-formyl-pyridinium iodide (I-37) promoted the conversion of L-alanine (I-
33) to keto-acid I-34 through Schiff base intermediates I-35 and I-36 (Scheme 1.8).25  






These experiments focused on understanding the role of PLP in transamination.71 In their 
studies, they showed a number of PLP mimics could act as competent reaction partners to perform 
the biomimetic synthesis of keto-acid I-34 in a half-transamination.   
Kudra and co-workers have studied the ability of PLP mimics to catalyze racemization of 
amino acids.26 Their experiments started with an enantioenriched isomer of phenylglycine 
(Scheme 1.9). After submitting I-38 to phosphate buffer conditions in the presence of an achiral 
PLP mimic I-39, they were able to isolate a completely racemic product I-40 in good yields.  
Scheme 1.9: PLP Mimic Catalyzed Racemization of Phenylglycine  
 
 
Building from Kudra’s example PLP-mediated racemization, recently Aron and co-
workers have demonstrated the ability to control racemization to give exclusively one enantiomer 
from a racemic mixture of phenylalanine (Scheme 1.10).  






In their dynamic kinetic resolution, they identified zinc complexes of I-42 that, when 
introduced to an esterase called alcalase, provided a single enantiomer of amino acid product I-
44.27 This is one of many examples of how utilizing PLP mimic catalysis can deliver good yielding 
products with high enantioselectivities.28  
1.4 NADH as Nature’s Hydride Source 
Nicotinamide adenine dinucleotide (NADH) is a cofactor found in biological systems that 
has inspired the development of small molecules as a natural hydride source. NADH was first 
discovered by Harden and Young in 1906 when studying alcohol fermentation.29 In 1936, Warburn 
identified NADH as the hydride transfer source in biological redox reactions.30 In their work, they 
described the mechanism for hydride transfer as a reversible reaction where NAD+ I-45 oxidizes 
alcohol I-47 in the forward direction and NADH I-46 reduces ketone I-47 in the reverse (Scheme 
1.11).  







Kaplan and others have shown that NADH is responsible for the catalytic activity of a 
number of dehydrogenase and reductase enzymes (Scheme 1.12).31, 32 Although NADH acts as a 
stoichiometric reagent in biological reductions, NAD+ is in turn an oxidant that can easily be 
reduced.   
Scheme 1.12: Enzymatic Dihydrofolate Reductase by NAD+ and NADH 
 
 
In the 1950s, researchers began studying the possibility of using other nicotinamide 
derivatives as a reducing agent. It was shown that NADH can be replaced by other pyridine bases 
without the loss of the coenzyme function in various biological systems.33-35 Kaplan and co-
workers demonstrated nicotinamide variants could provide reactivities rivaling that of NAD+, 
some of which are shown in Figure 1.4.  
Figure 1.4: Early Examples of NAD+ Variants 
 
 
Given its potential as an organic reducing reagent, NADH mimics have been an important 





dihydropyridine dicarboxylate (I-55) in 1882 that would eventually serve as such a molecule 
(Figure 1.5).36 Experiments on what is known as the Hantzsch ester continued, but it wasn’t until 
after the discovery of the function of NADH in the 1930s that the Hantzsch ester was used as an 
organic reducing agent.37-39  
Figure 1.5: Hantzsch Ester 
 
 
A recent example of such was reported by the List group in development of an asymmetric 
transfer hydrogenation catalyzed by a chiral Brønsted acid (Scheme 1.13).40 In this work, List 
showed a highly enantioselective imine reduction were I-55 served as the hydride source. Before 
the development of NADH mimics, powerful asymmetric reductions where commonly catalyzed 
by metals using stoichiometric quantities of metal hydride reagents.40  








1.5 Summary for Chapter 1 
The development of cofactor mimics inspired by biological systems has had a dramatic 
influence on the field of organocatalysis. The idea of using small molecules that mimic cofactors 
in biological systems is of interest to the Clift group. Specifically, we are interested in developing 

















Development of Quinone-Catalyzed Oxidative C–C Bond 








Portions of this chapter will appear in the following publication: 
Haugeberg, B. J.; Phan, J. H.; Liu, X.; O’Connor, T. J.; Clift, M. D. “Homologation of α-Aryl 
Amino Acids through Quinone-Catalyzed Decarboxylation/Mukaiyama-Mannich Addition.” 
Manuscript submitted. 
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Chapter 2 Quinone Cofactor Mimics 
In Chapter 1, we explored the use of cofactor mimics as organocatalysts – a concept that 
has led to the discovery of many new reactions. This chapter will focus on the development of a 
new method for amino acid homologation that is catalyzed by a topaquinone cofactor mimic.  
2.1 Introduction to Quinone Cofactors and Their Applications in Organocatalytic Reactions  
Owing to their ability to oxidize amines in biological systems, quinones have become a 
reagent of interest in organic synthesis. In the 1990s, Mure and Klinman studied the active site of 
amine oxidases in detail where they reported copper-containing amine oxidases catalyze the 
oxidative deamination of primary amines (II-1) to their corresponding aldehydes (II-2).41 In their 
work, they identified a topa-quinone cofactor (TPQ, II-3) responsible for promoting the amine 
oxidation (Scheme 2.1) from experiments using varying classes of bovine serum amine oxidase 
(BSAO).42 
Scheme 2.1: Discovery of TPQ as Cofactor in Active Site of BSAO 
 
 
Having identified the cofactor responsible for amine oxidation, Mure and Klinman 
proposed a general mechanism for quinone-containing monoamine oxidases. (Scheme 2.2).43 





iminoquinone intermediate II-7. A subsequent deprotonation event occurs at the hydrogen on the 
α-carbon to deliver N-aryl imine II-8. Then, hydrolysis of imine II-8 delivers keto-acid II-6 and 
a reduced form of the quinone (II-5). A copper-promoted oxidation returns the active quinone 
species II-3 to complete the catalytic cycle.  
Scheme 2.2: Mechanism of Topa-quinone Oxidation of Amino Acid 
 
 
Following elucidation of the active cofactor species, they conducted a series of experiments 
examining the ability of TPQ mimics to oxidize amines. During these studies, they developed 
conditions for the aerobic oxidation of benzylamine (II-9) into homo-dimeric imine products 








Scheme 2.3: Quinone-Catalyzed Amine Oxidation Developed by Mure and Klinman 
 
 
The Stahl group has parlayed Mure and Klinman’s discovery of aerobic oxidation of 
primary benzylic amines (II-14) by using a quinone (II-16) as a catalyst (Scheme 2.4).46 They 
were able to develop conditions for quinone-catalyzed aerobic cross-coupling of primary benzylic 
amines to afford secondary imines (II-15) using mild reaction conditions. This contribution 
demonstrates transimidation could be promoted selectively by primary amine derivatives (such as 
aniline based compounds, II-13) that are incapable of undergoing quinone-promoted oxidation. 
The development of this quinone-catalyzed process by Stahl inspired the Clift group to pursue the 
use of quinone organocatalysts in amine functionalization reactions. 







Initial research in the Clift group focused on exploring the formal quinone-catalyzed α-C–H 
bond functionalization of primary amines. Methods for α-functionalization of α-C–H bonds in 
secondary and tertiary amines are well known;47-49 however α-functionalization of primary amines 
is far less developed. By combining quinone-catalyzed amine oxidation with established imine 
addition protocols,50 the Clift group sought to develop a method for primary amine 
functionalization. Ultimately the successful development of a new method for formal C−H 
functionalization using a sequential, one pot quinone-catalyzed amine oxidation/nucleophilic 
addition process was achieved along with the discovery of a commercially available quinone 
catalyst for aerobic amine oxidation (Scheme 2.5). These studies set the stage for the discovery of 
related quinone-catalyzed reactions.  
Scheme 2.5: Formal Quinone-Catalyzed Amine Functionalization  
 
 
2.2 β-Amino Acid Synthesis via Oxidative-Decarboxylation/Mukaiyama−Mannich Addition 
After concluding this work, we began to envision other potential applications for quinone 
organocatalysis. One potential application is α-amino acid homologation to enable β-amino acid 
synthesis. β-amino acid derivatives have become valuable synthetic targets owing to their ability 
to resist protease degradation and stabilize protein structure, and their use as designer β-peptides 





approved pharmaceutical agents II-20–II-22 (Figure 2.1). We sought to develop a new method to 
access these important compounds via quinone-promoted α-amino acid homologation. 53-57  
Figure 2.1: Selected β-Amino Acid-Derived Pharmaceuticals 
 
 
2.2.1 Classical Methods for β-Amino Acid Synthesis 
Over the years, a number of methods have been developed to carry out α-amino acid 
homologation. The Arndt−Eistert homologation is a commonly employed method designed to 
convert carboxylic acids to a higher carbonyl homologue (Scheme 2.6).58, 59  
Scheme 2.6: Arndt-Eistert Homologation 
 
 
In a multi-step procedure, the described Arndt−Eistert homologation for α-amino acids (II-
23) begins with protecting the amine, followed by converting the carboxylic acid to an acid 





catalyst, the diazoketone (II-24) will undergo a Wolff-type rearrangement to give the homologated 
product (II-25). Although it has been widely employed for α-amino acid homologations, this 
method requires the use of a very dangerous reagent (diazomethane) and an expensive metal 
catalyst.  
The Kowalski ester homologation was specifically designed to avoid the use of 
diazomethane to provide a safer means for α-amino acid homologation (Scheme 2.7). Kowalski 
showed esters treated with pre-formed dibromomethyllithium, followed by a strong base at low 
temperature, could afford intermediate α,α-dibromoenolate (II-27). Subsequent addition of n-
butyllithium results in lithium-halogen exchange and rearrangement provides on ynolate 
intermediate (not shown), which upon quenching with the appropriate alcohol, results in 
production of the homologation product II-28.60 
Scheme 2.7: Kowalski Ester Homologation 
 
 
While these reactions, and their contemporary counterparts61-64 have been broadly 
employed, they typically require multi-step synthetic operations, utilize costly or dangerous 
reagents, and proceed through highly reactive intermediates. Therefore, developing a new protocol 
for amino acid homologation that proceeds in fewer steps under mild conditions is desirable. We 





Specifically, we envisioned that a quinone-catalyst could enable α-amino acid 
decarboxylation to provide an imine, which could be trapped in-situ via Mukaiyama−Mannich 
addition to provide the homologated product (Figure 2.2).  
Figure 2.2: Proposed Mechanism for Quinone-Catalyzed Amino Acid Functionalization  
 
 
We expected that first an amino acid (II-23) would condense with the quinone catalyst II-
19. At this point, instead of deprotonation at the α-position of the amino acid, a base would 
deprotonate the more acidic carboxylic acid, in turn promoting a decarboxylation of II-29 to 
provide the N-aryl imine II-30. This species would readily undergo transimidation with a stable 
N-protected amine to afford an N-protected imine product II-32. The active catalyst would then 





II-32 to a Mukaiyama−Mannich addition using silyl ketene acetal II-33. Subsequent deprotection 
would provide the homologation product II-34. Our studies began with an examination of the 
oxidative-decarboxylation, as this step was unprecedented.  
2.3 Development of Oxidative-Decarboxylation: Substrate Scope and Reaction Conditions 
We began by examining the potential of phenylglycine to undergo oxidative-
decarboxylation in the presence of quinone catalyst II-19 (Table 2.1). Phenylglycine was chosen 
as a test substrate for reaction optimization because the expected imine product would be incapable 
of tautomerization. In initial experiments, the organic solvents tested provided only heterogeneous 
reaction mixtures, resulting in no observed product formation (entries 1-3, 0%). Using a DMSO 
solvent also produced a heterogeneous reaction mixture, but provided the first observation of imine 
formation (entry 4, 39%). Prior to this point, we anticipated that one of the free amines in the 
reaction mixture would act as a base to promote decarboxylation. In entry 5, triethylamine was 
added as a base, which provided a slightly better yield (entry 5, 42%). Increasing the reaction 
temperature in DMSO solvent showed improvement but insufficient conversion (entry 6, 68%,) 
and using only water as the solvent provided low solubility of other organic reagents (entry 7, 
63%).  
At this point, biphasic conditions were explored using Acetonitrile:water at 80˚C (entry 8, 
74%), along with a variety of catalyst loadings and bases (entries 9-13, 75-90%), This led to the 
discovery of optimal biphasic conditions (entry 14, 91%). At this point, we recognized the 
presence of water in the reaction mixture may interfere with subsequent Mukaiyama−Mannich 





conditions (entry 15, 70%), and increasing the reaction temperature provided an excellent yield of 
92% (entry 16). Entries 16 and 17 suggests solvent polarity is an important factor for promoting 
quinone-catalyzed oxidative-decarboxylation as an ethanol solvent provides good yields while 
isopropanol does not (entry 17, 10%).  
Table 2.1: Reaction Discovery and Optimization  
 
  
These results prompted a study on the scope of oxidative-decarboxylation using a range of 
amino acids. With knowledge of the results from the study, we would then begin developing a 





2.3.1 Scope of Oxidative-Decarboxylation in Acetonitrile:Water 
With both sets of optimized conditions in hand (entries 14 and 16, Table 2.1), the oxidative-
decarboxylation was studied on a variety of amino acids that were either purchased from 
commercial sources or synthesized by a Petasis reaction.67  Determining which amino acids the 
quinone catalyst II-19 could oxidize was expected to provide information regarding the application 
of this method to β-amino acid synthesis. The results are summarized in Table 2.2. The imine 
product provided from oxidative-decarboxylation of phenylglycine was isolated in 85% yield 
(entry 1). When analyzing para-substituted aryl glycines, election withdrawing groups provided 
generally higher yields than did electron donating groups with yields ranging from 85-87% (entries 
9-12). The aryl substituents with electron donating substituents at the para position gave notably 
lower yields (entry 7, 76%, entry 8, 78%). It should be noted that oxidation of aryl glycine to lend 
imine II-46 also required increased catalyst loading presumably owing to the strong electron 
donating ability of the methoxy group. II-42 was isolated in the highest yield at 95%. Substitution 
at the ortho-position of the aryl rings showed no steric bias while at the same time mirrored the 
para- substitution in terms of electronic effects (entry 3, 86% and entry 2, 75%). A vinylogous aryl 
substituent was also tolerated, providing II-51 in 69% yield, indicating α-aryl substituents are not 
required (entry 13). Hetro-aromatic substituents are also suitable reaction partners (entry 5, 80% 








Table 2.2: Isolated Yields for Oxidative-Decarboxylation with Acetonitrile:Water Solvent  
 
 
One limitation of this protocol is that it fails to oxidize any natural amino acids (entries 14-
18, 0% yields).  From these results, we presume sp2 hybridization at the carbon β to the amine is 





carbons more readily accept electron density from the C–C bond cleavage event of the 
decarboxylation. This proposal is supported when analyzing trends in substituted aryl glycines 
where electron rich substituents lead to reduced yields whereas electron poor substituents lead to 
higher yields. Another possible explanation for not observing oxidative decarboxylation products 
of natural amino acids is potential decomposition of the imine products. The products in entries 
14-18 could tautomerize under reaction conditions to their corresponding enamines and form 
Mannich products. It should be noted such products have not been observed. Further discussion 
on the mechanism for oxidative-decarboxylation can be found in later sections (Section 2.5). 
2.3.2 Scope of Oxidative-Decarboxylation in EtOH 
 Although there is evidence to the contrary, we recognized the presence of water in the 
reaction mixture may interfere with subsequent Mukaiyama−Mannich additions.68, 69 To better 
prepare for this potential limitation, a similar substrate scope study was conducted using the 
optimized conditions wherein ethanol was employed as the solvent (Table 2.3).  
In these experiments, products of electron donating substituents (II-40, 97% and II-45, 
98%) gave yields that rivaled their electron withdrawing counterparts (entry 3, 97%, entry 8, 98%, 
entry 9, 98%, entry 10, 99%) and an electron rich hetroaromatic amino acid substrate gave a high 
yield (II-43, 92%). II-46 was provided in 88% yield, also higher than under the previous 
conditions with half the catalyst loading, albeit requiring longer reaction time. Unfortunately, 







Table 2.3: NMR Yields for Oxidative-Decarboxylation with EtOH Solvent 
 
 
2.3.3 Study of Amine Reaction Partners Other Than Anisidine 
A study to assess the possibility of utilizing other N-protected amines for the transimidation 
event was also conducted (Table 2.4). α-Methylbenzyl amine derivatives provided good yields 
(entry 1, 91% and entry 2, 97%) in the described process, which was anticipated on the basis of 
previous results.6 The imine products derived from this amine could be synthetically useful in 





Table 2.4: Substrate Scope for Primary Amine Coupling Partners 
 
 
Benzylamines could also promote transimidation (entry 3, 75% and entry 4, 45%), but 
reactions showed significant quantities of homo-coupled imine products, resulting in lower yields. 
This should not be surprising considering that quinone-catalyzed amine oxidations of such 





the reaction outcome, indicating bulky groups may hinder condensation of the amine to the 
quinone catalyst leading to increased efficiency (entries 3 and 4).  Benzyhydryl amine derivatives 
were tolerated at increased catalyst loading (entry 5, 78% and entry 6, 72%), forming 
phenylmethanimines products. An alkyl amine (entry 7, 90%) provided a high yield but required 
a super stoichiometric equivalence due to amine volatility under the elevated temperature of the 
reaction conditions. Aside from the results from benzylamine reaction partners, the quinone-
catalyzed oxidation proceeds selectively with amino acid decarboxylation over C–H oxidation. 
2.4 Development of Conditions for β-amino ester synthesis  
With the capability to generate electrophilic imine intermediates via quinone-catalyzed 
oxidative-decarboxylation of amino acids, we next pursued the development of a new method for 
β-amino acid synthesis through acid catalyzed Mukaiyama−Mannich addition (Table 2.5). In 
developing a protocol for a streamlined two-step, one-pot synthesis, we began by testing addition 
reactions with a known, robust silyl ketene acetal (SKA) nucleophile (II-65) using imines 
generated via quinone-catalyzed oxidative-decarboxylation in acetonitrile:water.28,29  We started 
by testing potential Lewis acid catalysts, but found very limited success (entries 1-4, 0-13%). This 
may be a result of the excess amine species in the reaction mixture binding with the Lewis acids. 
Using catalytic tetrafluoroboric acid (HBF4) provided a promising initial addition result (entry 5, 
24%), and super stoichiometric amounts of HBF4 were able to promote the desired reactivity in 
good yield (entry 8, 87%). The amount of HBF4 required to promote addition may be a result of 





proto-desilylation in the presence of HBF4. Therefore, addition of super stoichiometric amounts 
of both reagents is required to obtain efficient addition.  
Table 2.5: Optimization of Two-Step, 1-Pot β-Amino Ester Synthesis 
 
 
With the optimized conditions in hand, SKA (II-66, II-67, and II-68) additions that would 
yield true homologation products were attempted, but each failed to add into the imine intermediate 
under the optimized conditions (entries 9-11, 0%). Fortunately, replacing acetonitrile:water with 
EtOH, which could easily be removed under reduced pressure after imine formation solved this 
problem (entry 12, 89%). By using THF as a solvent for Mukaiyama−Mannich addition, the 





II-66 and II-68 were tested using this protocol, and we found that II-68 provided the best result 
(entry 13, 0%, entry 14, 74%). 
2.4.1 β-Amino Ester Synthesis Using gem-Dimethyl Silyl Ketene Acetal Nucleophile 
With proper conditions in place, the subsequent two-step, one-pot procedure was studied 
with the gem-dimethyl silyl ketene acetal (II-65) using a variety of aryl glycine derivatives. Using 
phenylglycine as the substrate, the homologated product was isolated in 89% yield (Table 2.6, 
entry 1).  







Although electronic effects did not seem to significantly alter addition yields, steric effects 
were more prominently noticed. The ortho-substituted aryl imines seemed less susceptible to 
addition from the relatively bulky nucleophile, as ortho-methyl product II-72 was determined to 
only yield 15% by 1H NMR, while a smaller ortho-chloro group provided product II-73 in 65% 
yield (entry 2 and 3).70 The meta-substituted product II-74 was isolated in the best yield at 94% 
(entry 4).  
In terms of para-substituted substrates, electronic factors seem to have minimal influence 
of reaction efficiency as all electron donating and electron withdrawing substituents tested were 
isolated in yields at or above 80% (entries 5-9). An electron rich heteroaromatic species II-80 also 
was isolated in 82% yield. From these results, a clear steric bias was noticed when comparing 
ortho- and para- substituted imines of the same substitution. The ortho-methyl product II-72 was 
isolated in a much lower yield than its para-substituted counterpart (entries 2 and 5), and this trend 
was also observed when testing the chlorinated derivatives (entry 3, II-73, 65% and entry 8, II-78, 
87%). 
2.4.2 β-Amino Ester Synthesis Using Silyl Ketene (Thio)Acetal Nucleophile 
In order to perform a true amino acid homologation, the aryl glycine derivatives were then 
subjected to nucleophilic addition with a silyl ketene (thio)acetal (Table 2.7). In line with the trends 
noticed previously, ortho-substituted aryl glycines again show steric effects. Ortho-methyl 
substituted phenylglycine provided the lowest yield of all substrates (entry 2, 56%) while ortho-





the chlorine atom, experiencing reduced steric hindrance of nucleophilic addition.30  The meta-
substituted II-85 was isolated in 78%.   
Table 2.7: Scope Studies using Silyl Ketene (Thio)acetal Nucleophile 
 
Electronic effects do not seem to have a strong influence on the addition as indicated by 
mostly good yields of entries 5-9 (72-94%). Electron rich heteroaromatic species were tolerated 
by this process (entry 10, 77%). Again, information regarding steric effects can be gleaned by 
comparing electronically similar ortho- and para- substituted glycine derivatives. Although both 
ortho- and para-chlorinated substituents provide excellent yields (entry 3, 95%, entry 8, 94%), the 
ortho- and para-methyl derivatives show significant differences in product formation (entry 2, 





2.4.3 Deprotection of Homologation Products 
The described process demonstrates conversion of an α-amino acid into a β-amino acid 
derivative bearing an N-PMP-protected amine. Although in many synthetic applications, protected 
amines, as well as esters, are more easily manipulated than unprotected amines and carboxylic 
acids, an amine deprotection was carried out to provide the free amine (Scheme 2.9). Using cerium 
ammonium nitrate (CAN) as an oxidant, PMP deprotection was easily achieved in high yields to 
afford the corresponding products of direct amino acid homologation (II-92 and II-93).71 
Scheme 2.9: Deprotection of Homologation Products 
 
 
2.5 Mechanistic Studies for Quinone-Catalyzed Oxidative-Decarboxylation  
 The previously described method for quinone-catalyzed oxidative-decarboxylation has a 
significant limitation, the inability to oxidize naturally occurring amino acids. Initial speculation 
leads us to believe this limitation can be overcome through catalyst design. In order to understand 
the properties that will ultimately provide a functional catalyst, we must determine what hinders 
the current system from promoting oxidative-decarboxylation of natural amino acids. We expect 





will provide the appropriate knowledge to design a catalyst capable of carrying out the desired 
transformations.  
2.5.1 Hammett Analysis on Quinone-Catalyzed Oxidative-Decarboxylation 
 A Hammett analysis was conducted to provide evidence for the rate-determining step 
(RDS) of quinone-catalyzed amino acid decarboxylation.72 In this set of experiments, a series of 
commercially available aryl glycine derivatives with varying substituents in the para-position were 
utilized.  In each case, the initial rate of the reaction for a given para-substituent X (expressed as 
kX) was assessed using 1H NMR. These rates (kX) were compared with the baseline rate of the 
reaction where X = H (expressed as kH), and the logarithm of the quotient kX/kH was plotted as 
a function of the Hammett parameter σ para.32 A series of expected possible results is discussed in 
Figure 2.3. 






If step 1 were rate-determining, one would expect a ϱ value of 0, as substitution of the aryl 
amino acid should not dictate its ability to condense with the quinone. A positive ϱ value may be 
an indication that step 2 or step 3 are rate-determining. In step 2, the decarboxylation could shift 
electron density to the benzylic carbon.73  In step 3, a transimidation event would provide a positive 
ϱ value, as a decrease in positive charge would be expected from pyramidalization.74   
The initial rates for oxidative decarboxylation were determined and the data is shown in 
Figure 2.4. Using this data to construct a Hammett Plot revealed a ϱ value, indicating negative 
charge density accumulates at the reaction center (Figure 2.5). This observation allows for the 
elimination of proposed steps 1 and 4 as potential RDS, but leaves us to differentiate between steps 
2 and 3 as potential RDS. If step 2 was rate determining, this positive ϱ value could indicate a 
negative charge build up resulting from decarboxylation. If step 3 was rate determining, this 
positive ϱ value could indicate a decrease in positive charge would be expected from 
pyramidalization of the imine during transamination. For complete mechanistic elucidation, 
further experimentation is needed.  







Figure 2.5: Hammett Plot for Quinone-Catalyzed Oxidative-Decarboxylation 
 
 
2.5.2 Hammett Analysis on Stoichiometric Quinone-Promoted Oxidative-Decarboxylation 
 In order to obtain more information on the decarboxylation step in the catalytic cycle, we 
recorded rate data for the oxidative decarboxylation event by monitoring a stoichiometric quinone-
promoted decarboxylation of α-aryl amino acids. This would eliminate the transimidation step and 
allow a more direct analysis of decarboxylation. α-Aryl amino acids were submitted to conditions 
with 1.0 equiv. of quinone (II-19) in the absence of anisidine, and conversion was measured by 




































As expected, the rates for stoichiometric decarboxylation were much faster than the 
catalytic process. Again, a Hammett plot was constructed and revealed a positive ϱ value, 
indicating negative charge density accumulation occurs at the reaction center (Figure 2.6). It was 
also observed that the ϱ value for both quinone-catalyzed and stoichiometric quinone-promoted 
oxidative-decarboxylation were very similar (ϱ =0.5331 and ϱ =0.4831). Although these studies 
are not conclusive, the results provide evidence to support decarboxylation as the RDS. If this is 
indeed the case, a more electron deficient catalyst may encourage decarboxylation of natural α- 







Figure 2.7: Hammett Plot for Stoichiometric Quinone-Promoted Oxidative-Decarboxylation 
 
 
2.6 Quinone-Catalyzed Amino Alcohol Deformylation  
 Following the development of quinone-catalyzed oxidative-decarboxylation, we sought to 
explore the potential of quinone catalysts in related oxidative C–C bond cleavage reactions. One 
specific idea we decided to test was the oxidative-deformylation of amino alcohols. A 
deformylation process is comparable to decarboxylation, but is fundamentally distinct in that the 
oxidative decarboxylation of amino acids requires sp3–sp2 C–C bond cleavage, while amino 
alcohol deformylation would proceed through sp3-sp3 C–C bond cleavage. It is our interest to 
develop conditions for quinone-catalyzed amino alcohol deformylation, an unreported 
transformation.  
2.6.1 Development of Quinone-Catalyzed Amino Alcohol Deformylation  
We expected deformylation of amino alcohols to proceed through a similar mechanism as 































with the quinone catalyst II-19. At this point, a base would deprotonate the O–H bond of the amino 
alcohol, in turn promoting a deformylation of II-109 to provide the N-aryl imine II-30. This 
species would readily undergo transimidation with a stable N-protected amine to give an N-
protected imine product II-32. The active catalyst would then be regenerated through auto-
oxidation. We began our studies by examining the oxidative-deformylation of phenylglycinol.   
Figure 2.8: Proposed Mechanism for Quinone-Catalyzed Amino Alcohol Deformylation   
 
 
2.6.2 Optimization of Quinone-Catalyzed Amino Alcohol Deformylation  
Deformylation of amino alcohols to imine products would provide the first example of 
quinone promoted sp3 C−C bond cleavage. Initial experiments using phenylglycinol (II-111) as 





conditions initially developed for oxidative-decarboxylation (Table 2.8); these conditions 
provided II-64 in 18% yield (entry 1). A subsequent reaction was attempted under identical 
conditions, but using 2-(tert-butyl)-5-hydroxycyclohexa-2,5-diene-1,4-dione (II-16) as the 
quinone catalyst. After 24 hours the PMP-protected imine II-64 was formed in 38% yield (entry 
2). Following these initial experiments, other solvents were studied at elevated temperatures with 
varied catalyst loading. Isopropanol seemed to promoted better oxidation with respect to both 
catalysts (entry 3, 44%, entry 4, 59%), and hydroxy-quinone II-16 provided a much better yield in 
ethanol than quinone II-19 (entry 5, 31%, entry 6, 75%).  







To our surprise, when triethylamine was not included as a base, yields increased when 
comparing entries with otherwise identical conditions (entry 7, 47%, entry 8, 71%, entry 9, 73%).  
Taking the best result and employing higher catalyst loading delivered the imine product in 99% 
yield (entry 10). The catalyst loading can be reduced to 10 mol % but the yield drops and an 
extended reaction time is required (entry 11, 85%). These results demonstrate quinone-catalyzed 
deformylation of amino alcohols have been realized. 
2.6.3 Preliminary Scope Studies for Quinone-Catalyzed Deformylation  
 With an optimized condition in hand (entry 10, Table 2.9), the oxidative deformylation 
was studied. We began with an isomer of phenylglycinol, which provided imine II-64 in 99% yield 
and complete conversion (entry 2). In thinking this observation could be a result of either C–C 
bond cleavage promoted by amine condensation to the quinone or by the alcohol, a diol was 
submitted to the reaction conditions to find no conversion after 24 hours (entry 3, 0%). A series of 
amino alcohols will be studies in the future to determine a full extent of the substrate scope.  






2.7 Summary for Chapter 2 
We have developed a new protocol for sequential quinone-catalyzed oxidative-
decarboxylation/Mukaiyama−Mannich addition to provide an efficient method for α-amino acid 
homologation under mild reaction conditions （20 substrates, 15–95% yield). This is the first 
application of quinone-catalyzed oxidative-decarboxylation. This method is currently limited to 
aryl amino acids, and studies directed at addressing this limitation are underway. We have also 
developed a protocol for quinone-catalyzed oxidative-deformylation of amino alcohols. Currently, 
we have developed conditions for deformylation of phenylglycinol, and plan to continue this 
project by studying the scope of this reaction using various aryl glycinols and amino ethers.  
 
2.8 General Experimental Section 
All reactions were carried out in 8 mL reaction vials with magnetic stirring unless 
otherwise stated. EtOH was used as purchased from Fisher Chemical (190 Proof). Other reagents 
were used as delivered from commercial sources. Purification of reaction products was carried out 
by flash chromatography using Fisher Chemical silica gel (230-400 Mesh, Grade 60). Analytical 
thin layer chromatography (TLC) was performed on EMD millipore TLC silica gel 60 – F 254: 25 
glass plates. Visualization was accomplished with UV light and/or phosphomolybdic acid staining 
followed by heating. Melting point data were recorded using a Digimelt SRS. Film and KBr pellet 
infrared spectra were recorded using a Shimadzu FTIR-8400S. 1H-NMR spectra were recorded on 
a Bruker Advance 400 (400 MHz) or a Bruker 500 (500 MHz) spectrometer and are reported in 





apparent, s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, b = broad); integration; 
coupling constant(s) in Hz. Proton-decoupled 13C-NMR spectra were recorded on a Bruker 500 
(125 MHz) and are reported in ppm using solvent as a reference (CDCl3 at 77.16 ppm). Mass 
spectra data were obtained on a Micromass Ltd. LCT Premier quadrupole and time-of-flight 
tandem mass analyzer. 
 
2.9 General Experimental Procedures for Sequential Oxidative–Decarboxylation/Mannich 
Addition 
A: General procedure for glycine derivative decarboxylation/ silyl ketene (thio)acetal 
addition (II-82-II-90): 
To a solution of 2,6-di-tert-butyl-1,4-benzoquinone (11.0 mg, 0.050 mmol, unless 
otherwise noted) and p-anisidine (123.1 mg, 1.0 mmol) in ethanol (1.6 mL, 0.312 M) with respect 
to the glycine substrate) was added the glycine derivative (0.50 mmol), followed by purging the 
reaction vial with a balloon of O2. The reaction mixture was allowed to stir under O2 at 70 oC for 
24 h unless otherwise noted.  The ethanol was removed by rotary evaporation and the oxidative-
decarboxylation product was further pumped for 0.5h with a high-vacuum pump. The remaining 
solid was dissolved in dry THF (1.6 mL, 0.312 M) and the solution was cooled to 0 oC. To this 
solution was added tetrafluoroboric acid solution (48 wt. % in H2O, 90.0 L, 0.75 mmol) and silyl 
ketene (thio)aceta1 (1.5 mmol). The resulting solution was allowed to stir for 1.5h under N2 at 0 






oC. Sodium phosphate buffer (pH = 7, 2 mL) was added followed by saturated aq. NaHCO3 (0.5 
mL). The mixture was transferred to a separatory funnel by aid of Et2O, shaken vigorously and the 
organic phase was collected. The aqueous phase was further extracted with Et2O (3 x 5.0 mL) and 
the combined organic extracts were dried (Na2SO4), filtered and concentrated under reduced 
pressure. Flash chromatography on TEA neutralized silica gel (10% ethyl acetate in hexanes) 
provided the desired aryl amine thioesters (II-82-II-91). 
 
B: General Procedure for Glycine Derivative Decarboxylation/ Silyl Ketene Acetal Addition 
(II-71-80): 
To a solution of 2,6-di-tert-butyl-1,4-benzoquinone (11.0 mg, 0.050 mmol, unless 
otherwise noted) and p-anisidine (123.1 mg, 1.0 mmol) in ethanol (1.6 mL, 0.312 M) with respect 
to the glycine substrate) was added the glycine derivative (0.50 mmol) , followed by purging the 
reaction vial with a balloon of O2. The reaction mixture was allowed to stir under O2 at 70 oC for 
24 h unless otherwise noted.  The ethanol was removed by rotary evaporation and the oxidative-
decarboxylation product was further pumped for 0.5h with a high-vacuum pump. The remaining 
solid was dissolved in dry THF (1.6 mL, 0.312 M) and the solution was cooled to 0 oC. To this 
solution was added tetrafluoroboric acid solution (48 wt. % in H2O, 90.0 L, 0.75 mmol) and silyl 
ketene (gem-dimethyl)acetal (1.5 mmol) dropwise over 6 iterations by 15 min intervals. After 1.5 
h, the solvent was removed under reduced pressure. Flash chromatography on TEA neutralized 
silica gel (5%-20% ethyl acetate in hexanes) followed by recrystallization in CHCl3 and pentane 






C: General Procedure for Aryl Glycine Decarboxylation (II-39-51):  
To a solution of 2,6-di-tert-butyl-1,4-benzoquinone (22.0 mg, 0.10 mmol, unless otherwise 
noted) and p-anisidine (246 mg, 2.0 mmol) in Acetonitrile:water (3.2 mL, 0.312 M with respect 
to the glycine substrate) was added the glycine derivative (1.00 mmol) , followed by purging the 
reaction vial with a balloon of O2. The reaction mixture was allowed to stir under O2 at 50
 oC for 
24 h unless otherwise noted. The crude reaction mixture was placed in a reparatory funnel and the 
organic layer was extracted in H2O and CHCl3 followed by concentration. Flash chromatography 
on TEA neutralized silica gel (5%-20% ethyl acetate in hexanes) followed by recrystallization 
(when described) in CHCl3 and pentane provided the desired imine II-39-51). 
 
D: General Procedure for Quinone-Catalyzed Amino Alcohol Deformylation:  
To a solution of 2,6-di-tert-butyl-1,4-benzoquinone (22.0 mg, 0.10 mmol, unless otherwise 
noted) and p-anisidine (123 mg, 1.0 mmol) in EtOH (1.6 mL, 0.312 M with respect to the glycinol 
substrate) was added the glycine derivative (0.50 mmol), followed purging the reaction vial with 
a balloon of O2. The reaction mixture was allowed to stir under O2 at 70
 oC. After 24h, crude 
reaction mixtures concentrated under reduced pressure and 1H NMR analysis was conducted. 
 
 





(E)-N-(4-methoxyphenyl)-1-phenylmethanimine (II-39): The reaction was carried out 
according to the general oxidation procedure (C) using 2-Phenylglycine (151 mg, 1.00 
mmol) to provide after purification product II-39 (178.8 mg, 85%) as an orange crystal. 
IR (KBr) 2955, 2837, 1622 cm-1. 1H NMR (400 MHz, CDCl3) 8.49 (s, 1H), 7.90 (m, 2H), 7.47 
(m, 3H), 7.25 (d, J = 8.7 Hz, 2H), 6.94 (d, J = 8.9 Hz, 2H), 3.84 (s, 3H). 13C NMR (101 MHz, 
CDCl3) 158.2, 158.1, 144.7, 136.3, 130.8, 128.5, 128.4, 122.0, 114.2, 55.3. HMRS (ESI): Exact 
mass calcd for C14H13NO [M+H], 212.1075. Found 212.1056. 
 
(E)-N-(4-methoxyphenyl)-1-(o-tolyl)methanimine (II-40): The reaction was 
carried out according to the general oxidation procedure (C) using 2-amino-2-(o-
tolyl)acetic acid (165.2 mg, 1.00 mmol) to provide after purification product II-40 
(169.6 mg, 75%) as a white crystal; IR (KBr), 2968, 2841, 1616 cm-1. 1H NMR (400 MHz, CDCl3) 
8.77 (s, 1H), 8.07 (dd, J = 7.6, 1.6 Hz, 1H), 7.32 (m, 3H), 7.22 (d, J = 8.8 Hz, 2H), 6.94 (d, J = 
8.9 Hz, 2H), 3.84 (s, 3H), 2.59 (s, 3H). 13C NMR (101 MHz, CDCl3) 158.2, 157.2, 145.6, 138.3, 
134.4, 131.0, 130.7, 127.6, 126.3, 122.2, 114.4, 55.5, 19.4. HMRS (ESI): Exact mass calcd for 
C15H15NO [M+H], 226.1232. Found 226.1211. 
 
(E)-1-(2-chlorophenyl)-N-(4-methoxyphenyl)methanimine (II-41): The reaction 
was carried out according to the general oxidation procedure (C) using 2-amino-2-(2-
chlorophenyl)acetic acid (185.6 mg, 1.00 mmol) to provide after purification product 





CDCl3) 8.94 (s, 1H), 8.23 (dd, J = 7.0, 2.5 Hz, 1H), 7.38 (m, 3H), 7.28 (d, J = 8.9 Hz, 1H), 6.95 
(d, J = 8.9 Hz, 2H), 3.84 (s, 3H). 13C NMR (126 MHz, CDCl3) 158.8, 154.9, 144.8, 135.9, 133.6, 
131.9, 130.1, 128.5, 127.2, 122.7, 114.5, 55.7. HMRS (ESI): Exact mass calcd for C14H12NOCl 
[M+H], 246.0686. Found 246.0666. 
 
(E)-1-(3-fluorophenyl)-N-(4-methoxyphenyl)methanimine (II-42): The reaction 
was carried out according to the general oxidation procedure (C) using 2-amino-2-  (3-
fluorophenyl)acetic acid (169.2 mg, 1.00 mmol) to provide after purification product 
II-42 (219.0.0 mg, 95%) as a white crystal; IR (KBr) 3082, 2843, 1622 cm-1. 1H NMR (500 MHz, 
CDCl3) 8.46 (s, 1H), 7.65 (ddd, J = 9.6, 2.7, 1.5 Hz, 1H), 7.61 (dt, J = 7.7, 1.3 Hz, 1H), 7.43 (td, 
J = 7.9, 5.6 Hz, 1H), 7.25 (d, J = 8.9 Hz, 2H), 7.16 (tdd, J = 8.3, 2.7, 1.0 Hz, 1H), 6.94 (d, J = 8.9 
Hz, 2H), 3.84 (s, 3H). 13C NMR (101 MHz, CDCl3) 163.2 (d, J = 246.6 Hz), 158.6, 156.68 (d, J 
= 3.1 Hz), 144.3, 138.8 (d, J = 7.3 Hz), 130.2 (d, J = 7.9 Hz), 124.7 (d, J = 2.8 Hz), 122.3, 117.9 
(d, J = 21.7 Hz), 114.4 (d, J = 22.2 Hz), 114.4, 55.5. HMRS (ESI): Exact mass calcd for 
C14H12NFO [M+H], 230.0981. Found 230.0958. 
 
(E)-N-(4-methoxyphenyl)-1-(p-tolyl)methanimine (II-43): The reaction was carried 
out according to the general oxidation procedure (C) using 2-amino-2-(p-tolyl)acetic acid 
(165.2 mg, 1.00 mmol) to provide after purification product II-43 (186. mg, 76%) as a 
white crystal: IR (KBr) 2912, 2885, 1624 cm-1. 1H NMR (400 MHz, CDCl3) 8.44 (s, 1H), 





2H), 3.83 (s, 3H), 2.42 (s, 3H). 13C NMR (101 MHz, CDCl3) 158.6, 158.3, 145.3, 141.6, 134.1, 
129.6, 128.7, 122.3, 114.5, 55.7, 21.8. HMRS (ESI): Exact mass calcd for C15H15NO [M+H], 
226.1232. Found 226.1205. 
 
(E)-N,1-bis(4-methoxyphenyl)methanimine (II-44): The reaction was carried out 
according to the general oxidation procedure (C), using 2-amino-2-  (4-methoxyphenyl) 
acetic acid (181.1, 0.50 mmol) and 20 mol % quinone catalyst to provide after 
purification product II-44 (93.5 mg, 78%) as a white crystal; IR (KBr) 2956, 2839, 1622 
cm-1. 1H NMR (500 MHz, CDCl3) 8.41 (s, 1H), 7.83 (d, J = 8.8 Hz, 2H), 7.21 (d, J = 8.9 Hz, 1H), 
6.98 (d, J = 8.8 Hz, 2H), 6.92 (d, J = 9.0 Hz, 1H), 3.87 (s, 3H), 3.83 (s, 3H). 13C NMR (126 MHz, 
CDCl3) 162.11, 158.07, 158.06, 145.41, 130.38, 129.62, 122.20, 114.47, 114.28, 55.64, 55.56. 
HMRS (ESI): Exact mass calcd for C15H15NO2 [M+H], 242.1181. Found 242.1156. 
 
(E)-1-(4-fluorophenyl)-N-(4-methoxyphenyl)methanimine (II-45): The reaction was 
carried out according to the general oxidation procedure (C) using 2-amino-2-(4-
fluorophenyl)acetic acid (169.2 mg, 1.00 mmol) to provide after purification product II-
45 (193.9 mg, 85%) as a white crystal; IR (KBr) 3016, 2879, 1622 cm-1. 1H NMR (500 
MHz, CDCl3) 8.44 (s, 1H), 7.89 (m, 2H), 7.23 (d, J = 8.9 Hz, 2H), 7.15 (m, 2H), 6.94 (d, J = 8.9 
Hz, 2H), 3.84 (s, 3H). 13C NMR (126 MHz, CDCl3) 164.6 (d, J = 251.6 Hz), 158.4, 156.97, 144.8, 
132.9 (d, J = 3.1 Hz) 130.6 (d, J = 8.7 Hz), 122.3, 116.0 (d, J = 22.0 Hz), 114.5, 55.6. HMRS 






(E)-1-(4-chlorophenyl)-N-(4-methoxyphenyl)methanimine (II-46):The reaction was 
carried out according to the general oxidation procedure (C) using 2-amino-2-(4-
chlorophenyl)acetic acid (185.6 mg, 1.00 mmol) to provide after purification product II-
46 (214.1 mg, 87%) as a white crystal; IR (KBr) 2962, 2839, 1620 cm-1. 1H NMR (500 
MHz, CDCl3) 8.45 (s, 1H), 7.83 (d, J = 8.5 Hz, 2H), 7.44 (d, J = 8.5 Hz, 2H), 7.24 (d, J = 8.9 Hz, 
2H), 6.94 (d, J = 8.9 Hz, 2H), 3.84 (s, 3H). 13C NMR (126 MHz, CDCl3) 158.6, 156.8, 144.6, 
137.1, 135.1, 129.8, 129.2, 122.4, 114.6, 55.7. HMRS (ESI): Exact mass calcd for C14H12NOCl 
[M+H], 246.0686. Found 246.0668. 
 
(E)-1-(4-bromophenyl)-N-(4-methoxyphenyl)methanimine (II-47): The reaction was 
carried out according to the general oxidation procedure (C) using 2-amino-2-  (4-
bromophenyl)acetic acid (230.1 mg, 1.00 mmol) to provide after purification product II-
47 (248.3 mg, 86%) as a white crystal; IR (KBr) 2960, 2879, 1622 cm-1. 1H NMR (400 
MHz, CDCl3) 8.43 (s, 1H), 7.76 (d, J = 8.2 Hz, 2H), 7.60 (d, J = 8.2 Hz, 2H), 7.24 (d, J = 8.6 Hz, 
2H), 6.94 (d, J = 8.6 Hz, 2H), 3.84 (d, J = 1.0 Hz, 3H). HMRS (ESI): Exact mass calcd for 






(E)-N-(4-methoxyphenyl)-1-(4-(trifluoromethyl)phenyl)methanimine (II-48): The 
reaction was carried out according to the general oxidation procedure (C) using 4-
trifluoromethyl-phenylglycine (219.2 mg, 1.00 mmol) to provide after purification 
product II-48 (240.9 mg, 86%) as a white crystal; IR (KBr) 2881, 1622 cm-1. 1H NMR 
(500 MHz, CDCl3) 8.54 (s, 1H), 8.00 (m, 2H), 7.72 (d, J = 8.0 Hz, 2H), 7.28 (d, J = 8.9 Hz, 2H), 
6.95 (d, J = 8.9 Hz, 2H), 3.85 (s, 3H). 13C NMR (126 MHz, CDCl3) 158.9, 156.4, 144.2, 139.7, 
132.49 (q, J = 32.6 Hz), 128.8, 125.82 (q, J = 3.8 Hz), 125.15 (q), 122.54 (d), 114.6, 55.7.  HMRS 
(ESI): Exact mass calcd for C15H12F3NO [M+H], 280.0949. Found 280.0919.  
 
(1E,2E)-N-(4-methoxyphenyl)-3-phenylprop-2-en-1-imine (II-49): The reaction 
was carried out according to the general oxidation procedure (C) 2-amino-4- 
phenylbut-3-enoic acid (177.7 mg, 1.00 mmol) to provide after purification product II-
49 (151.2 mg, 69%) as a white crystal; IR (KBr) 2956, 2837, 1629 cm-1. 1H NMR (400 
MHz, CDCl3) 8.30 (dd, J = 5.4, 2.9 Hz, 1H), 7.53 (m, 2H), 7.37 (m, 3H), 7.21 (d, J = 8.7 Hz, 2H), 
7.12 (m, 2H), 6.92 (d, J = 8.7 Hz, 2H), 3.83 (d, J = 1.0 Hz, 3H).  HMRS (ESI): Exact mass calcd 
for C16H15NO [M+H], 238.1232. Found 238.1207. 
 
(E)-N-(4-methoxyphenyl)-1-(thiophen-2-yl)methanimine (II-50): The reaction was 
carried out according to the general oxidation procedure (C) using 2-amino-2-(thiophen-
2-yl)acetic acid (157.2 mg, 1.00 mmol) to provide after purification product II-50 (173.2. 





(s, 1H), 7.49 (dd, 2H), 7.25 (d, J = 8.6 Hz, 2H), 7.15 (t, J = 4.3 Hz, 1H), 6.94 (d, J = 8.5 Hz, 2H), 
3.85 (d, J = 1.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) 158.4, 151.2, 144.5, 143.3, 131.6, 129.8, 
127.8, 122.4, 114.5, 55.6. HMRS (ESI): Exact mass calcd for C12H12NSO [M+H], 218.0640. 
Found 218.0632. 
 
(E)-1-(furan-2-yl)-N-(4-methoxyphenyl) methanimine (II-51): The reaction was 
carried out according to the general oxidation procedure (C) using 2-amino-2-(furan-2-
yl)acetic acid (141.1 mg, 1.00 mmol) and 20 mol % quinone catalyst to provide after 
purification product II-51 (106.8. mg, 53%) as a white crystal: IR (KBr) 3093, 2958, 1622 cm-1. 
1H NMR (400 MHz, CDCl3) 8.30 (s, 1H), 7.59 (s, 1H), 7.26 (d, J = 8.7 Hz, 2H), 6.91 – (m, 3H), 
6.54 (dt, J = 3.1, 1.4 Hz, 1H), 3.82 (s, 3H). 13C NMR (101 MHz, CDCl3) 158.6, 152.5, 145.9, 
145.5, 144.4, 122.4, 115.6, 114.6, 112.2, 55.6. HMRS (ESI): Exact mass calcd for C12H12NO2 
[M+H], 202.0868. Found 202.0854. 
 
S-ethyl 3-((4-methoxyphenyl)amino)-3-phenylpropanethioate (II-82):  The 
reaction was carried out according to the general procedure (A) using 2-
Phenylglycine (75.6 mg, 0.50 mmol) to provide after purification product II-







S-ethyl 3-((4-methoxyphenyl)amino)-3-(o-tolyl)propanethioate (II-83): 
The reaction was carried out according to the general procedure (A) using 2-
amino-2-(o-tolyl)acetic acid (82.6 mg, 0.50 mmol) to provide after 
purification product II-83 (92.8 mg, 56%) as an orange oil; IR (film) 3523, 3055, 2962, 1676 cm-
1. 1H NMR (400 MHz, CDCl3) 7.41 (d, 1H , J = 5.6 Hz), 7.21 – 7.11 (m, 3H), 6.68 (d, 2H, J = 8.3 
Hz), 6.45 (d, 2H, J = 8.3 Hz), 4.94 (dd, 1H , J = 8.4, 5.0 Hz), 3.69 (s, 3H), 2.87 (m, 4H), 2.45 (s, 
3H), 1.21 (t, 3H , J = 7.4 Hz). 13C  NMR (126 MHz, CDCl3) 197.7, 152.4, 141.2, 140.0, 134.9, 
130.9, 127.4, 126.8, 125.4, 114.90, 114.87, 55.8, 53.1, 50.2, 23.8, 19.3, 14.7; HMRS (ESI): Exact 
mass calcd for C19H24NO2S [M+H+], 330.1528. Found 330.1536. 
 
S-ethyl 3-(2-chlorophenyl)-3-((4-methoxyphenyl)amino)propanethioate 
(II-84): The reaction was carried out according to the general procedure (A) 
using 2-amino-2-(2-chlorophenyl)acetic acid (92.8 mg, 0.50 mmol) while 1 
equivalent of silyl ketene (thio)acetal (0.50 mmol)  was added and the addition was repeated twice 
after each 30 min to provide after purification product II-84 (166.6mg, 95%) as an orange oil. IR 
(film) 3390, 3062, 2966, 1674 cm-1. 1H NMR (500 MHz, CDCl3) 7.45 – 7.41 (m, 1H), 7.40 – 7.37 
(m, 1H), 7.22 – 7.14 (m, 2H), 6.72 – 6.63 (m, 2H), 6.47 – 6.38 (m, 2H), 5.13 (dd, 1H, J = 9.0, 3.7 
Hz), 4.57 (bs, 1H), 3.68 (s, 3H), 3.09 (dd, 1H, J = 14.6, 3.7 Hz), 2.98 – 2.67 (m, 3H), 1.21 (t, 3H, 
J = 7.5 Hz). 13C  NMR (126 MHz, CDCl3) 197.7, 152.4, 140.6, 138.9, 132.7, 130.0, 128.7, 127.9, 
127.4, 114.9, 114.8, 55.8, 53.6, 49.1, 23.8, 14.7; HMRS (ESI): Exact mass calcd for 







(II-85): The reaction was carried out according to the general procedure (A) 
using 2-amino-2-(3-fluorophenyl)acetic acid (84.6 mg, 0.50 mmol) to provide 
after purification product II-85 (130.1mg, 78%) as an orange solid, m.p. 84 oC. IR (KBr pellet) 
3402, 3070, 2989, 1672 cm-1. 1H NMR (400 MHz, CDCl3) 7.32 – 7.27 (m, 1H), 7.16 (d, 1H, J = 
7.7 Hz, ), 7.09 (dt, 1H, J = 9.8, 2.1 Hz), 6.93 (app td, 1H), 6.70 (d, 2H, J = 8.7 Hz, 1H), 6.51 (d, 
2H, J = 8.3 Hz), 4.74 (t, 1H, J = 6.7 Hz), 3.70 (s, 3H), 2.98 (d, 2H, J = 6.6 Hz), 2.86 (q, 2H, J = 
7.4 Hz), 1.21 (t, 3H, J = 7.4 Hz). 13C  NMR (126 MHz, CDCl3)  197.3, 163.3 (d, J = 247.0 Hz), 
152.6, 145.2 (d, J = 6.3 Hz), 140.6, 130.4 (d, J = 7.6 Hz), 122.1 (d, J = 2.5 Hz), 115.3, 114.9, 
114.5 (d, J = 21.4 Hz), 113.4 (d, J = 22.7 Hz),  56.4,  55.8, 51.5, 23.8, 14.7；HMRS (ESI): Exact 
mass calcd for C18H21NO2SF [M+H+], 334.1277. Found 334.1281. 
 
S-ethyl 3-((4-methoxyphenyl)amino)-3-(p-tolyl)propanethioate (II-86): 
The reaction was carried out according to the general procedure (A) using 2-
amino-2-(p-tolyl)acetic acid (82.6 mg, 0.50 mmol) to provide after purification 
product II-86 (146.2mg, 89%) as a brown solid, m.p. 68 oC. IR (KBr) 3398, 
3041, 2904, 1681 cm-1. 1H NMR (500 MHz, CDCl3) 7.25 (d, 2H, J = 8.1 Hz), 7.13 (d, 2H, J = 7.8 
Hz), 6.69 (d, 2H, J = 9.0 Hz), 6.51 (d, 2H, J = 8.9 Hz), 4.73 (t, 1H, J = 6.8 Hz), 3.69 (s, 3H), 2.98 
– 2.92 (m, 2H), 2.86 (q, 2H, J = 7.4 Hz), 2.32 (s, 3H), 1.21 (t, 3H, J = 7.4 Hz). 13C  NMR (126 









(II-87): The reaction was carried out according to the general procedure (A) 
using 2-amino-2-(4-methoxyphenyl)acetic acid (120.6 mg, 0.50 mmol) while 
the reaction was stirred for 48h in ethanol at 70oC to provide after purification 
product II-87 (151.8mg, 88%) as a lilac solid, m.p. 74 oC. IR (KBr pellet) 3384, 3068, 2929, 1676 
cm-1. 1H NMR (400 MHz, CDCl3) 7.29 (s, 1H), 6.87 – 6.82 (m, 2H), 6.71 – 6.67 (m, 2H), 6.52 
(d, 2H, J = 8.9 Hz), 4.71 (dd, 1H, J = 7.8, 5.7 Hz), 3.78 (s, 3H), 3.69 (s, 3H), 3.00 – 2.91 (m, 2H), 
2.89 – 2.81 (q, 2H, J = 7.4 Hz,), 1.20 (t, J = 7.4 Hz, 3H). 13C  NMR (126 MHz, CDCl3) 197.6, 
158.8, 152.4, 140.8, 134.1, 127.4, 115.2, 114.7, 114.1, 56.1, 55.7, 55.3, 51.7, 23.6, 14.6; HMRS 
(ESI): Exact mass calcd for C19H24NO3S [M+H+], 346.1477. Found 346.1469.   
 
S-ethyl 3-(4-fluorophenyl)-3-((4-methoxyphenyl)amino)propanethioate 
(II-88): The reaction was carried out according to the general procedure (A) 
using 2-amino-2-(4-fluorophenyl)acetic acid (84.6 mg, 0.50 mmol) to provide 
after purification product II-88 (139.8mg, 84%) as an orange solid, m.p. 90 oC. IR (KBr pellet) 
3371, 3016, 2983, 1668 cm-1. 1H NMR (400 MHz, CDCl3) 7.33 (m, 2H), 7.00 (app t, 2H), 6.69 
(d, 2H, J = 8.9 Hz), 6.50 (d, 2H, J = 8.9 Hz), 4.76 – 4.70 (t, 1H, J = 6.7 Hz), 3.70 (s, 3H), 2.97 (m, 





(d, J = 243.8 Hz), 152.6, 140.7, 137.9, 128.1(d, J = 8.8 Hz), 115.8 (d, J = 21.4 Hz), 115.4, 114.8, 




(II-89): The reaction was carried out according to the general procedure (A) 
using 2-amino-2-(4-chlorophenyl)acetic acid (92.8 mg, 0.50 mmol) to provide 
after purification product II-89 (164.5mg, 94%) as an orange oil. IR (film) 
3382, 3060, 2929, 1666 cm-1. 1H NMR (400 MHz, CDCl3) 7.33 – 7.27 (m, 4H), 6.69 (d, J = 8.9 
Hz, 2H), 6.48 (d, J = 8.8 Hz, 2H), 4.72 (t, 1H, J = 6.7 Hz), 3.69 (s, 3H), 2.98 – 2.92 (m, 2H), 2.86 
(q, J = 7.4 Hz, 2H), 1.21 (t, J = 7.4 Hz, 3H). 13C  NMR (126 MHz, CDCl3) 197.3, 152.6, 140.9, 
140.7, 133.2, 129.1, 127.9, 115.3, 114.8, 56.1, 55.8, 51.6, 23.8, 14.7; HMRS (ESI): Exact mass 
calcd for C18H21ClNO2S [M+H+], 350.0982. Found 350.0984. 
 
 S-ethyl 3-(4-bromophenyl)-3-((4-methoxyphenyl)amino)propanethioate 
(II-90): The reaction was carried out according to the general procedure (A) 
using 2-amino-2-(4-bromophenyl)acetic acid (115.0 mg, 0.50 mmol) to 
provide after purification product II-90 (142.0mg, 72%) as a dark orange solid, m.p. 70 oC. IR 
(KBr pellet) 3392, 3056, 2960, 1679 cm-1. 1H NMR (500 MHz, CDCl3) 7.46 – 7.42 (m, 2H), 7.26 
– 7.23 (m, 2H), 6.69  (d, 2H, J = 8.9 Hz), 6.48 (d, 2H, J = 8.9 Hz), 4.70 (t, 1H, J = 6.7 Hz), 3.69 





MHz, CDCl3) 197.3, 152.7, 141.3, 140.5, 132.0, 128.3, 121.4, 115.4, 114.9, 56.3, 55.8, 51.5, 




91): The reaction was carried out according to the general procedure (A) using 
2-amino-2-(thiophen-2-yl)acetic acid (78.6 mg, 0.50 mmol) to provide after 
purification product II-91 (123.3 mg, 77%) as an orange oil. IR (film) 3369, 3066, 2929, 1666 cm-
1. 1H NMR (500 MHz, CDCl3) 7.18 (dd, 1H, J = 5.0, 1.2 Hz), 6.98 (app dt, 1H), 6.93 (dd, 1H, J = 
5.0, 3.5 Hz), 6.78 – 6.69 (m, 2H), 6.66 – 6.58 (m, 2H), 5.09 (dd, 1H, J = 7.1, 6.0Hz), 4.19 (bs, 
1H), 3.72 (s, 3H), 3.13 (dd, 1H, J = 15.0, 7.4 Hz), 3.07 (dd, 1H, J = 14.9, 5.6 Hz), 2.88 (q, 2H, J 
= 7.4 Hz), 1.22 (t, 3H, J = 7.4 Hz). 13C  NMR (126 MHz, CDCl3) 197.1, 152.9, 147.1, 140.5, 
126.9, 124.4, 124.0, 115.8, 114.8, 55.7, 52.8, 51.4, 23.7, 14.7; HMRS (ESI): Exact mass calcd 
for C16H20NO2S2 [M+H+], 322.0935. Found 322.0906 
 
 methyl 3-((4-methoxyphenyl)amino)-2,2-dimethyl-3-phenylpropanoate 
(II-71): The reaction was carried out according to the general oxidation 
procedure (B) using 2-Phenylglycine (75.6 mg, 0.50 mmol) to provide after 
purification product II-71 (140.0. mg, 89%) as a white crystal; m.p. 87.7°C; IR (KBr) 3369, 2955, 
1716 cm-1; 1H NMR (400 MHz, CDCl3) 7.32 – 7.22 (m, 4H), 7.24 – 7.18 (m, 1H), 6.63 (d, 2H, J 





(101 MHz, CDCl3) 177.3, 152.1, 141.3, 139.5, 128.5, 128.1, 127.5, 114.9, 114.8, 65.4, 55.8, 52.2, 




propanoate (II-72): The reaction was carried out according to the general 
oxidation procedure (B) using 2-amino-2-(o-tolyl)acetic acid (82.6 mg, 0.50 
mmol) to provide after purification product II-72, (15% by NMR) as a white crystal; m.p. 87.4°C; 
IR (KBr) 3389, 3066, 2831, 1742 cm-1; 1H NMR (400 MHz, CDCl3) 7.24 (s, 1H), 7.15 – 7.08 (m, 
3H), 6.64 (d, 2H, J = 8.9 Hz), 6.43 (d, 2H J = 8.4 Hz), 4.82 (s, 1H), 3.68 (s, 3H), 3.66 (s, 3H), 
2.50 (s, 3H), 1.26 (s, 3H), 1.21 (s, 3H); 13C  NMR (101 MHz, CDCl3) 177.5, 152.2, 136.7, 130.6, 
130.6, 127.3, 127.2, 126.0, 126.0, 114.9, 114.9, 60.3, 55.8, 52.3, 48.4, 24.7, 20.6, 20.3; HMRS 
(ESI): Exact mass calcd for C20H25NO3 [M+H+], 328.1913. Found 328.1922. 
 
methyl 3-(2-chlorophenyl)-3-((4-methoxyphenyl)amino)-2,2-
dimethylpropanoate (II-73): The reaction was carried out according to the 
general oxidation procedure (B) using 2-amino-2-(2-chlorophenyl)acetic acid 
(92.8 mg, 0.50 mmol) to provide after purification product II-73 (112.3 mg, 65%) as a white 
crystal; m.p. 107.2 °C; IR (KBr) 3402, 2995, 2833, 1718 cm-1; 1H NMR (400 MHz, CDCl3) 7.39 
– 7.35 (m, 1H), 7.34 – 7.30 (m, 1H), 7.22 – 7.14 (m, 2H), 6.69 (d, 2H, J = 8.9 Hz), 6.51 (d, 2H, J 





CDCl3) 177.2, 152.2, 140.9, 137.8, 135.2, 129.6, 128.9, 128.7, 127.0, 114.9, 114.5, 60.1, 55.8, 




dimethylpropanoate (II-74): The reaction was carried out according to the 
general oxidation procedure (B) using 2-amino-2-(3-fluorophenyl)acetic acid 
(84.6 mg, 0.50 mmol) to provide after purification product II-74 (155.0 mg, 94%) as a white 
crystal; m.p. 118.1 °C; IR (KBr) 3389, 3066, 2901, 1707 cm-1; 1H NMR (400 MHz, CDCl3) 7.28 
– 7.22 (m, 1H), 7.07 (app dt, 1H), 7.00 (app dt, 1H), 6.93 (app tdd, 1H), 6.66 (d, 2H, J = 8.9 Hz), 
6.45 (d, 2H, J = 8.9 Hz), 4.44 (s, 1H), 3.67 (s, 3H), 3.67 (s, 3H), 1.26 (s, 3H), 1.17 (s, 3H); 13C  
NMR (101 MHz, CDCl3) 177.0, 162.9 (d, J = 245.9 Hz) , 152.3, 142.6 (d, J = 5.0 Hz), 141.0, 
129.5 (d, J = 8.1 Hz), 124.3 (d, J = 2.9 Hz), 115.3 (d, J = 21.7 Hz), 114.872, 114.870, 114.6 (d, J 
= 21.2 Hz), 65.1, 55.8, 52.3, 47.2, 24.6, 20.8; HMRS (ESI): Exact mass calcd for C19H22FNO3 
[M+H], 332.1662. Found 332.1651. 
 
methyl 3-((4-methoxyphenyl)amino)-2,2-dimethyl-3-(p-tolyl) propanoate 
(II-75): The reaction was carried out a according to the general oxidation 
procedure (B) using 2-amino-2-(p-tolyl)acetic acid (82.6 mg, 0.50 mmol) to 
provide after purification product II-75 (131.0 mg, 80%) as a white crystal; 





J = 7.9 Hz), 7.09 (d, 2H, J = 7.9 Hz), 6.65 (d, 2H, J = 8.9 Hz), 6.47 (d, 2H, J = 8.9 Hz), 4.44 (s, 
1H), 3.67 (s, 6H), 2.30 (s, 3H), 1.24 (s, 3H), 1.16 (s, 3H); 13C NMR (101 MHz, CDCl3) 177.3, 
152.0, 141.4, 137.1, 136.4, 128.8, 128.4, 114.9, 114.8, 65.1, 55.8, 52.2, 47.3, 24.6, 21.2, 20.6; 
HMRS (ESI): Exact mass calcd for C20H25NO3 [M+], 327.1834. Found 327.1845.  
 
methyl 3-(4-methoxyphenyl)-3-((4-methoxyphenyl)amino)-2,2-
dimethylpropanoate (II-76): The reaction was carried out according to the 
general oxidation procedure (B) using 2-amino-2-(4-methoxyphenyl) acetic 
acid (120.6 mg, 0.50 mmol) to provide after purification product II-76 (142.5 
mg, 83%) as a white crystal; m.p. 102.4 °C; IR (KBr) 3416, 2978, 2833, 1724 cm-1; 1H NMR (400 
MHz, CDCl3) 7.21 (d, 2H, J = 8.7 Hz), 6.84 (d, 2H, J = 8.7 Hz), 6.67 (d, 2H, J = 8.9 Hz), 6.48 (d, 
2H, J = 8.9 Hz), 4.43 (s, 1H), 3.79 (s, 3H), 3.69 (s, 3H), 3.68 (s, 3H), 1.26 (s, 3H), 1.18 (s, 3H); 
13C  NMR (101 MHz, CDCl3) 177.4, 159.0, 152.0, 141.4, 131.4, 129.5, 114.9, 114.8, 113.5, 64.7, 




dimethylpropanoate (II-77):  The reaction was carried out according to the 
general oxidation procedure (B) using 2-amino-2-(4-fluorophenyl)acetic acid 
(84.6 mg, 0.50 mmol) to provide after purification product II-77 (132.7 mg, 





CDCl3) 7.25 (dd, 2H, J = 8.5, 5.4 Hz), 6.98 (app t, 2H), 6.66 (d, 2H, J = 8.8 Hz), 6.44 (d, 2H, J = 
8.8 Hz), 4.44 (s, 1H), 3.67 (s, 3H), 3.66 (s, 3H), 1.25 (s, 3H), 1.16 (s, 3H); 13C  NMR (101 MHz, 
CDCl3) 177.1, 163.5, 161.0, 152.2, 141.1, 135.3 (d, J = 3.3 Hz), 129.9 (d, J = 8.0 Hz), 115.1 (d, J 
= 21.3 Hz), 114.8 (d, J = 2.3 Hz), 64.8, 55.8, 52.3, 47.2, 24.5, 20.7; HMRS (ESI): Exact mass 
calcd for C19H22FNO3 [M+H], 332.1662. Found 332.1653.  
 
methyl 3-(4-chlorophenyl)-3-((4-methoxyphenyl)amino)-2,2-
dimethylpropanoate (II-78): The reaction was carried out according to the 
general oxidation procedure (B) using 2-amino-2-(4-chlorophenyl)acetic acid 
(92.8 mg, 0.50 mmol) to provide after purification product II-78 (151.7 mg, 
87%) as a white crystal; m.p. 137.0 °C; IR (KBr) 3373, 2953, 2926, 1718 cm-1; 1H NMR (400 
MHz, CDCl3) 7.30 – 7.20 (m, 4H), 6.66 (d, 2H, J = 8.9 Hz), 6.44 (d, 2H, J = 8.9 Hz), 4.43 (s, 1H), 
3.68 (s, 3H), 3.67 (s, 3H), 1.26 (s, 3H), 1.16 (s, 3H); 13C  NMR (101 MHz, CDCl3) 177.0, 152.3, 
141.0, 138.2, 133.3, 129.8, 128.4, 114.9, 114.9, 64.9, 55.8, 52.3, 47.1, 24.5, 20.7; HMRS (ESI): 
Exact mass calcd for C19H22ClNO3 [M+], 347.1288. Found 347.1223. 
 
methyl 3-(4-bromophenyl)-3-((4-methoxyphenyl)amino)-2,2-
dimethylpropanoate (II-79):  The reaction was carried out according to the 
general oxidation procedure (B) using 2-amino-2-(4-bromophenyl)acetic acid 
(115.0 mg, 0.50 mmol) to provide after purification product II-79 (166.0. mg, 





MHz, CDCl3) 7.44 (d, 2H, J = 8.5 Hz), 7.19 (d, 2H, J = 8.4 Hz), 6.68 (d, 2H, J = 8.9 Hz), 6.45 (d, 
2H, J = 9.0 Hz), 4.43 (s, 1H), 3.70 (s, 3H), 3.69 (s, 3H), 1.27 (s, 3H), 1.18 (s, 3H); 13C  NMR (101 
MHz, CDCl3) 177.0, 152.2, 140.9, 138.8, 131.3, 130.2, 121.5, 114.9, 114.9, 65.0, 55.8, 52.3, 




yl)propanoate  (II-80): The reaction was carried out according to the general 
oxidation procedure (B) using 2-amino-2-(thiophen-2-yl)acetic acid (78.6 mg, 
0.50 mmol) to provide after purification product II-80 (131.0. mg, 82%) as a white crystal; m.p. 
85.9 °C; IR (KBr) 3356, 3109, 2910, 1716 cm-1; 1H NMR (400 MHz, CDCl3) 7.18 – 7.14 (m, 1H), 
6.94 – 6.90 (m, 2H), 6.70 (d, 2H, J = 8.9 Hz), 6.56 (d, 2H, J = 8.9 Hz), 4.77 (s, 1H), 3.69 (s, 6H), 
1.31 (s, 3H), 1.28 (s, 3H); 13C  NMR (101 MHz, CDCl3) 177.0, 152.6, 144.5, 141.1, 126.6, 126.1, 
124.5, 115.3, 114.8, 61.9, 55.8, 52.3, 47.6, 24.1, 21.3; HMRS (ESI): Exact mass calcd for 
C17H21SNO3 [M+], 319.1242. Found 319.1252.  
 
S-ethyl 3-((4-methoxyphenyl)amino)-3-phenylpropanethioate (II-92) : II-
82 (0.5 mmol) was dissolved in CH3CN (11 mL) and an aqueous solution of 
CAN (1.37g, 2.5 mmol in 8mL water) was added dropwise. The reaction mixture was stirred for 
2 h. NaHCO3 was added until pH 6 was reached. Sodium sulfite was then added until the mixture 





were dried over sodium sulfate, evaporated and the obtained free amine II-92 was provided (98.6 
mg, 94%) as a brown oil. IR (film) 3413, 3388,3037, 2927, 1673 cm-1. 1H NMR (400 MHz, D2O) 
7.55 – 7.43 (m, 5H), 4.85 (t, J = 7.3 Hz, 1H), 3.42 (d, J = 7.3 Hz, 2H), 2.86 (q, J = 7.5 Hz, 2H), 
1.15 (t, J = 7.4 Hz, 3H). 13C  NMR (126 MHz, D2O) 199.6, 134.6, 129.6, 129.3, 127.0, 51.8, 46.2, 
23.4, 13.5; HMRS (ESI): Exact mass calcd for C11H16NOS [M+H+], 210.0953. Found 210.0954.  
 
 methyl 3-amino-2,2-dimethyl-3-phenylpropanoate (II-93):  II-71 (0.5 
mmol) was dissolved in CH3CN (11 mL) and an aqueous solution of CAN 
(1.37g, 2.5 mmol in 8mL water) was added dropwise. The reaction mixture 
was stirred for 2 h. NaHCO3 was added until pH 6 was reached. Sodium sulfite was then added 
until the mixture became brown. The product was extracted with EtOAc (3 x 10 mL). The 
combined organic layers were dried over sodium sulfate, evaporated and the obtained free amine 
II-93 was provided (92.6 mg, 89%) as a brown solid; which was spectroscopically identical to 
previous reports.71  
 
2.11 Experimental Section for Hammett Experiments 
A: General Procedure for Mechanism Experiments on Quinone-Catalyzed Decarboxylation:  
To a solution of 2,6-di-tert-butyl-1,4-benzoquinone (22.0 mg, 0.10 mmol, unless otherwise 
noted) and p-anisidine (246 mg, 2.0 mmol) in EtOH (3.2 mL, 0.312 M with respect to the aryl 
glycine substrate) was added the glycine derivative (1.00 mmol), followed by addition of 1,3,5-





balloon of O2. The reaction mixture was allowed to stir under O2 at 70
 oC. Aliquots were drawn 
from the reaction mixture every hour for 1H NMR analysis and concentrated under reduced 
pressure. % yield was measured by product formation against the NMR standard and converted 
from % yield to concentration ([ ]) in mol/L.  
 
B: General Procedure for Mechanism Experiments on Stoichiometric Quinone-Promoted 
Decarboxylation:  
To a solution of 2,6-di-tert-butyl-1,4-benzoquinone (110.0 mg, 0.5 mmol, unless otherwise 
noted) and p-anisidine (123.0 mg, 1.0 mmol) in EtOH (1.6 mL, 0.312 M with respect to the glycine 
derivative substrate) was added the glycine derivative (0.50 mmol), followed by addition of 1,3,5-
trimethoxybenzene (0.50 mmol) as an internal NMR standard and purging the reaction vial with a 
balloon of O2. The reaction mixture was allowed to stir under O2 at 70
 oC. Aliquots were drawn 
from the reaction mixture every hour for 1H NMR analysis and concentrated under reduced 
pressure. % yield was measured by product formation against the NMR standard and converted 











Rate Data for Quinone-Catalyzed Decarboxylation of Phenylglycine:  
 


























Rate Data Plot for Linear Portion of Quinone-Catalyzed Decarboxylation: 
 
 
Rate Data for Quinone-Catalyzed Decarboxylation of 2-amino-2-(p-tolyl)acetic acid:  
 
 



























Rate Data Plot for Quinone-Catalyzed Decarboxylation of 2-amino-2-(p-tolyl)acetic acid:  
 
 

























[ II-45 ] vs. t
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Rate Data for Quinone-Catalyzed Decarboxylation of 2-amino-2-(4-methoxyphenyl)acetic 
acid: 
 
Rate Data Plot for Quinone-Catalyzed Decarboxylation of 2-amino-2-(4-methoxyphenyl) 


























Rate Data Plot for Linear Portion of Quinone-Catalyzed Decarboxylation of2-amino-2-(4-
methoxyphenyl) acetic acid:  
 
Rate Data for Quinone-Catalyzed Decarboxylation of 2-amino-2-(4-chlorophenyl)acetic 
acid: 
 

























Rate Data Plot for Quinone-Catalyzed Decarboxylation 2-amino-2-(4-chlorophenyl)acetic 
acid: 
 





















[ II-48 ] vs. t




























































Rate Data Plot for Linear Portion of Quinone-Catalyzed Decarboxylation 2-amino-2-(4-
bromophenyl)acetic acid: 
 
Rate Data for Quinone-Catalyzed Decarboxylation of 2-amino-2-(4-(trifluoromethyl)phenyl) 
acetic acid: 
 

























Rate Data Plot for Quinone-Catalyzed Decarboxylation 2-amino-2-(4-(trifluoromethyl) 
phenyl) acetic acid: 
 
 
Rate Data Plot for Linear Portion of Quinone-Catalyzed Decarboxylation2-amino-2-(4-





















[ II-50 ] vs. t

























Rate Data for Stoichiometric Quinone-Promoted Decarboxylation of Phenylglycine: 
 
 


































Rate Data for Stoichiometric Quinone-Promoted Decarboxylation of 2-amino-2-(p-
tolyl)acetic acid:  
 


























Rate Data Plot for Stoichiometric Quinone-Promoted Decarboxylation of 2-amino-2-(p-
tolyl)acetic acid: 
 























[ II-106 ] vs. t





























Rate Data for Stoichiometric Quinone-Promoted Decarboxylation of 2-amino-2-(4-
chlorophenyl)acetic acid: 
 



































































2.10 Chapter 1 and 2 References   
1. MacMillan, D. W., The advent and development of organocatalysis. Nature 2008, 455, 
304-8. 
2. Li, C. J.; Trost, B. M., Green chemistry for chemical synthesis. Proceedings of the 
National Academy of Sciences of the United States of America 2008, 105, 13197-202. 
3. Hajos, Z. G.; Parrish, D. R., Asymmetric synthesis of bicyclic intermediates of natural 
product chemistry. The Journal of Organic Chemistry 1974, 39, 1615-1621. 
4. Seayad, J.; List, B., Asymmetric organocatalysis. Organic & biomolecular chemistry 
2005, 3, 719-24. 
5. Bertelsen, S.; Jorgensen, K. A., Organocatalysis-after the gold rush. Chemical Society 
Reviews 2009, 38, 2178-2189. 
6. Ahrendt, K. A.; Borths, C. J.; MacMillan, D. W. C., New Strategies for Organic 
Catalysis:  The First Highly Enantioselective Organocatalytic Diels−Alder Reaction. Journal of 
the American Chemical Society 2000, 122, 4243-4244. 
7. Mukherjee, S.; Yang, J. W.; Hoffmann, S.; List, B., Asymmetric enamine catalysis. 
Chemical reviews 2007, 107, 5471-569. 
8. Rutter, W. J., Evolution of Aldolase. Federation proceedings 1964, 23, 1248-57. 
9. Stryer, L., Biochemistry, 4th ed. Freedman and Company1995. 
10. Jansen, B. C. P. D., W.F., On the isolation of antiberiberi vitamin. Koninklijke 
Nederlandse Akademie van Wetenschappen. 1926, 29, 1390. 
11. Williams, R. R.; Cline, J. K., Synthesis of Vitamin B1. Journal of the American Chemical 





12. Kluger, R.; Tittmann, K., Thiamin Diphosphate Catalysis: Enzymic and Nonenzymic 
Covalent Intermediates. Chemical reviews 2008, 108, 1797-1833. 
13. Mizuhara, S.; Handler, P., Mechanism of Thiamine-catalyzed Reactions. Journal of the 
American Chemical Society 1954, 76, 571-573. 
14. Wohler, F. L., J. , Untersuchungen über das Radikal der Benzoesäure. Annales 
pharmaceutiques françaises 1832, 3, 249-282. 
15. Lapworth, A., Reactions involving the addition of hydrogen cyanide to carbon 
compounds. Journal of the Chemical Society, Transactions 1903, 83, 995-1005. 
16. Breslow, R., On the Mechanism of Thiamine Action. IV.1 Evidence from Studies on 
Model Systems. Journal of the American Chemical Society 1958, 80, 3719-3726. 
17. Enders, D.; Balensiefer, T., Nucleophilic Carbenes in Asymmetric Organocatalysis. 
Accounts of Chemical Research 2004, 37, 534-541. 
18. Stetter, H., Die katalysierte Addition von Aldehyden an aktivierte Doppelbindungen – 
Ein neues Syntheseprinzip. Angewandte Chemie 1976, 88, 695-704. 
19. Enders, D.; Breuer, K.; Runsink, J.; Teles, J. H., The First Asymmetric Intramolecular 
Stetter Reaction. Preliminary Communication. Helvetica Chimica Acta 1996, 79, 1899-1902. 
20. Gyorgy, P., Vitamin B2 and the Pellagra-like Dermatitis in Rats. Nature 1934, 133, 498. 
21. Eliot, A. C.; Kirsch, J. F., Pyridoxal phosphate enzymes: mechanistic, structural, and 
evolutionary considerations. Annual review of biochemistry 2004, 73, 383-415. 
22. Voet, D. V., J. , Biochemistry. Wiley: New York, 1995 
23. Hayashi, H., Pyridoxal enzymes: mechanistic diversity and uniformity. Journal of 





24. John, R. A., Pyridoxal phosphate-dependent enzymes. Biochimica et biophysica acta 
1995, 1248, 81-96. 
25. Maley, J. R.; Bruice, T. C., Catalytic reactions involving azomethines. X. Transamination 
of 1-methyl-4-formylpyridinium iodide. Journal of American Chemical Society 1968, 90,  
2843-7. 
26. Tabushi, I.; Kuroda, Y.; Yamada, M., Racemization of phenylglycine catalyzed by 
pyridoxal. Catalytic effect of phosphate ion. Tetrahedron Letters 1987, 28, 5695-5698. 
27. Felten, A. E.; Zhu, G.; Aron, Z. D., Simplifying Pyridoxal: Practical Methods for Amino 
Acid Dynamic Kinetic Resolution. Organic Letters 2010, 12, 1916-1919. 
28. Toney, M. D., Controlling reaction specificity in pyridoxal phosphate enzymes. 
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2011, 1814, 1407-1418. 
29. Harden, A. Y., W. J. , The alcoholic ferment of yeast-juice. Proceedings of the Royal 
Society B: Biological Sciences 1906, 78, 369. 
30. Warburg, O. C., W. , Pyridin, der wasserstoffübertragende bestandteil von 
gärungsfermenten. Biochemistry. Z 1936, 287, 291. 
31. Anderson, B. M.; Kaplan, N. O., Enzymatic studies with analogues of diphosphopyridine 
nucleotide. The Journal of biological chemistry 1959, 234, 1226-32. 
32. Garrett, R. H. G., C. M. , Biochemistry. Saunders College Publishing1995. 
33. Kaplan, N. O.; Ciotti, M. M., The 3-Acetylpyridine Anologue of DPN1. Journal of the 
American Chemical Society 1954, 76, 1713-1714. 
34. Kaplan, N. O.; Ciotti, M. M., Chemistry and Properties of the 3-Acetylpyridine  





35. Kaplan, N. O.; Ciotti, M. M.; Stolzenbach, F. E., Reaction of Pyridine Nucleotide 
Analogues with Dehydrogenases. Journal of Biological Chemistry 1956, 221, 833-844. 
36. Hantzsch, A., Ueber die Synthese pyridinartiger Verbindungen aus Acetessigäther und 
Aldehydammoniak. Justus Liebigs Annalen der Chemie 1882, 215, 1-82. 
37. Dondoni, A.; Massi, A., Asymmetric organocatalysis: from infancy to adolescence. 
Angewandte Chemie (International ed. in English) 2008, 47, 4638-60. 
38. Eisner, U.; Kuthan, J., Chemistry of dihydropyridines. Chemical reviews 1972, 72, 1-42. 
39. Kuthan, J.; Kurfurst, A., Development in dihydropyridine chemistry. Industrial & 
Engineering Chemistry Product Research and Development 1982, 21, 191-261. 
40. Hoffmann, S.; Seayad, A. M.; List, B., A Powerful Brønsted Acid Catalyst for the 
Organocatalytic Asymmetric Transfer Hydrogenation of Imines. Angewandte Chemie 
International Edition 2005, 44, 7424-7427. 
41. Mure, M.; Klinman, J. P., Synthesis and spectroscopic characterization of model 
compounds for the active site cofactor in copper amine oxidases. Journal of the American 
Chemical Society 1993, 115, 7117-7127. 
42. Klinman, J. P., New Quinocofactors in Eukaryotes. Journal of Biological Chemistry 
1996, 271, 27189-27192. 
43. Mure, M., Tyrosine-Derived Quinone Cofactors. Accounts of Chemical Research 2004, 
37, 131-139. 
44. Mure, M.; Klinman, J. P., Model Studies of Topaquinone-Dependent Amine Oxidases. 1. 
Oxidation of Benzylamine by Topaquinone Analogs. Journal of the American Chemical Society 





45. Mure, M.; Klinman, J. P., Model Studies of Topaquinone-Dependent Amine Oxidases. 2. 
Characterization of Reaction Intermediates and Mechanism. Journal of the American Chemical 
Society 1995, 117, 8707-8718. 
46. Wendlandt, A. E.; Stahl, S. S., Chemoselective Organocatalytic Aerobic Oxidation of 
Primary Amines to Secondary Imines. Organic Letters 2012, 14, 2850-2853. 
47. Wendlandt, A. E.; Stahl, S. S., Modular o-Quinone Catalyst System for Dehydrogenation 
of Tetrahydroquinolines under Ambient Conditions. Journal of the American Chemical Society 
2014, 136, 11910-11913. 
48. Burger, E. C.; Tunge, J. A., Synthesis of Homoallylic Amines via the Palladium-
Catalyzed Decarboxylative Coupling of Amino Acid Derivatives. J. Am. Chem. Soc. 2006, 128, 
10002-10003. 
49. Noble, A.; MacMillan, D. W. C., Photoredox α-Vinylation of α-Amino Acids and N-Aryl 
Amines. Journal of the American Chemical Society 2014, 136, 11602-11605. 
50. Kobayashi, S.; Mori, Y.; Fossey, J. S.; Salter, M. M., Catalytic Enantioselective 
Formation of C-C Bonds by Addition to Imines and Hydrazones: A Ten-Year Update. Chemical 
reviews 2011, 111, 2626-2704. 
51. Cheng, R. P.; Gellman, S. H.; DeGrado, W. F., β-Peptides:  From Structure to Function. 
Chemical reviews 2001, 101, 3219-3232. 
52. Stephens, O. M.; Kim, S.; Welch, B. D.; Hodsdon, M. E.; Kay, M. S.; Schepartz, A., 
Inhibiting HIV Fusion with a β-Peptide Foldamer. Journal of the American Chemical Society 





53. Sleebs, B. E.; Van Nguyen, T. T.; Hughes, A. B., Recent advances in stereoselective 
synthesis and application of β-amino acids. Organic Preparations and Procedures International  
2009, 41, 429-478. 
54. Bandala, Y.; Juaristi, E. In Recent developments in the synthesis of β-amino acids2009 
Wiley-VCH Verlag GmbH & Co. KGaA; pp 291-365. 
55. Weiner, B.; Szymanski, W.; Janssen, D. B.; Minnaard, A. J.; Feringa, B. L., Recent 
advances in the catalytic asymmetric synthesis of [small beta]-amino acids. Chemical Society 
Reviews 2010, 39, 1656-1691. 
56. Chhiba, V.; Bode, M.; Mathiba, K.; Brady, D. In Enzymatic stereoselective synthesis of 
β-amino acids2014 Wiley-VCH Verlag GmbH & Co. KGaA; pp 297-313. 
57. Juaristi, E. S., V. A. , Enantioselective Synthesis of B-Aminoacids, 2nd ed. Wiley-
Interscience: New York, 2005 
58. Arndt, F.; Eistert, B., Ein Verfahren zur Überführung von Carbonsäuren in ihre höheren 
Homologen bzw. deren Derivate. Berichte der deutschen chemischen Gesellschaft (A and B 
Series) 1935, 68, 200-208. 
59. Ellmerer-Mueller, E. P.; Broessner, D.; Maslouh, N.; Tako, A., Synthesis of N-{[(9H-
fluoren-9-yl)methoxy]carbonyl}-protected (Fmoc) β-amino acids (homo-α-amino acids) by 
direct homologation. Helv. Chim. Acta 1998, 81, 59-65. 
60. Kowalski, C. J.; Haque, M. S.; Fields, K. W. Ester homologation via α-bromo α-keto 
dianion rearrangement. Journal of the American Chemical Society 1985, 107, 1429-30. 
61. Guichard, G.; Abele, S.; Seebach, D., Preparation of N-Fmoc-protected β2- and β3-amino 
acids and their use as building blocks for the solid-phase synthesis of β-peptides. Helvetica 





62. Yang, H.; Foster, K.; Stephenson, C. R. J.; Brown, W.; Roberts, E., Asymmetric Wolff 
Rearrangement Reactions with α-Alkylated-α-diazoketones:  Stereoselective Synthesis of α-
Substituted-β-amino Acid Derivatives. Organic Letters 2000, 2, 2177-2179. 
63. Koch, K.; Podlech, J., Exceptionally simple homologation of protected α- to β-amino 
acids in the presence of silica gel. Synthetic Communications 2005, 35, 2789-2794. 
64. Pinho, V. D.; Gutmann, B.; Kappe, C. O., Continuous flow synthesis of β-amino acids 
from α-amino acids via Arndt-Eistert homologation. Royal Society of Chemistry Advances 2014, 
4, 37419-37422. 
65. Vander Zwan, M. C.; Hartner, F. W.; Reamer, R. A.; Tull, R., A new reaction of amino 
acids: conversion to benzoxazoles. Journal Organic Chemistry 1978, 43, 509-11. 
66. Vinsova, J.; Horak, V.; Buchta, V.; Kaustova, J., Highly lipophilic benzoxazoles with 
potential antibacterial activity. Molecules 2005, 10, 783-793. 
67. Petasis, N. A.; Zavialov, I. A., A New and Practical Synthesis of α-Amino Acids from 
Alkenyl Boronic Acids. Journal of the American Chemical Society 1997, 119, 445-446. 
68. Iimura, S.; Nobutou, D.; Manabe, K.; Kobayashi, S., Mannich-type reactions in water 
using a hydrophobic polymer-supported sulfonic acid catalyst. Chemical Communications 2003, 
1644-1645. 
69. Hamada, T.; Manabe, K.; Kobayashi, S., Enantio- and Diastereoselective, Stereospecific 
Mannich-Type Reactions in Water. Journal of the American Chemical Society 2004, 126, 7768-
7769. 






71. Onodera, G.; Toeda, T.; Toda, N.-n.; Shibagishi, D.; Takeuchi, R., Cationic iridium 
complex is a new and efficient Lewis acid catalyst for aldol and Mannich reactions. Tetrahedron 
2010, 66, 9021-9031. 
72. Hansch, C. L., A.; Taft, R. W. , A Survey of Hammett Substituent Constants and 
Resonance and Field Parameters. Chemical reviews 1991, 91, 165. 
73. Straub, T. S.; Bender, M. L., Cycloamyloses as enzyme models. Decarboxylation of 
benzoylacetic acids. Journal of the American Chemical Society 1972, 94, 8881-8888. 
74. Ciaccia, M.; Pilati, S.; Cacciapaglia, R.; Mandolini, L.; Di Stefano, S., Effective catalysis 
of imine metathesis by means of fast transiminations between aromatic-aromatic or aromatic-
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